| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |